(Q43902819)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18629570%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18629570%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18629570%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

P D Delmas

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18629570%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

English

0 references

publication date

16 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18629570%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18629570%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18629570%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18629570%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

1683-1704

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18629570%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00198-008-0660-9

10 January 2020

exact match

0 references

cites work

Increased bone resorption during the first year after stroke.

1 reference

https://api.crossref.org/works/10.1007%2FS00198-008-0660-9

Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-008-0660-9

Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-008-0660-9

Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-008-0660-9

Alendronate Prevents Postmenopausal Bone Loss in Women without Osteoporosis: A Double-Blind, Randomized, Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00198-008-0660-9

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

21 January 2018

1 reference

12 December 2020

Prediction of bone loss in postmenopausal women

1 reference

12 December 2020

Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women

1 reference

12 December 2020

Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane

1 reference

12 December 2020

Pathophysiology of bone loss in patients receiving anticonvulsant therapy.

1 reference

12 December 2020

Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women

1 reference

12 December 2020

Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients

1 reference

12 December 2020

Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolaemia

1 reference

12 December 2020

The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women

1 reference

12 December 2020

Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures

1 reference

12 December 2020

High bone turnover in the elderly

1 reference

12 December 2020

The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients

1 reference

12 December 2020

Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women

1 reference

12 December 2020

Pravastatin therapy increases procollagen I N-terminal propeptide (PINP), a marker of bone formation in post-menopausal women

1 reference

12 December 2020

Systemic effect comparisons of six inhaled corticosteroid preparations

1 reference

12 December 2020

Relationship between changes in bone mineral density and fracture risk reduction with antiresorptive drugs: some issues with meta-analyses

1 reference

12 December 2020

Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism

1 reference

12 December 2020

Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate

1 reference

12 December 2020

Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.

1 reference

12 December 2020

Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status

1 reference

12 December 2020

Prediction of rapid bone loss in postmenopausal women

1 reference

12 December 2020

Changes in bone density and turnover after alendronate or estrogen withdrawal.

1 reference

12 December 2020

Short-term reduction in bone markers with high-dose simvastatin

1 reference

12 December 2020

Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review

1 reference

12 December 2020

Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction

1 reference

12 December 2020

Biochemical markers of bone turnover are influenced by recently sustained fracture.

1 reference

12 December 2020

Biochemical markers of bone turnover in patients with thyroid dysfunctions and in euthyroid controls: a cross-sectional study

1 reference

12 December 2020

Relationships between physical activity and metacarpal cortical bone mass and bone resorption in hemiplegic patients

1 reference

12 December 2020

Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment.

1 reference

12 December 2020

Circadian variation in urinary excretion of bone collagen cross-links

1 reference

12 December 2020

Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Effect of calcium intake and physical activity level on bone mass and turnover in healthy, white, postmenopausal women.

1 reference

12 December 2020

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis

1 reference

12 December 2020

The effects of heparin and low molecular weight heparins on bone

1 reference

12 December 2020

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

1 reference

12 December 2020

Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women

1 reference

12 December 2020

Determinants of bone loss in elderly men and women: a prospective population-based study

1 reference

12 December 2020

The relation between lifestyle factors and biochemical markers of bone turnover among early postmenopausal women

1 reference

12 December 2020

Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy

1 reference

12 December 2020

Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women

1 reference

12 December 2020

The Proportion of Carboxylated to Total or Intact Osteocalcin in Serum Discriminates Warfarin-Treated Patients from Control Subjects

1 reference

12 December 2020

The effect of low dose micronized 17ss-estradiol on bone turnover, sex hormone levels, and side effects in older women: a randomized, double blind, placebo-controlled study

1 reference

12 December 2020

Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women.

1 reference

12 December 2020

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

1 reference

12 December 2020

Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy

1 reference

12 December 2020

Biochemical markers of bone resorption compared with estimates of bone resorption from radiotracer kinetic studies in osteoporosis

1 reference

12 December 2020

Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study.

1 reference

12 December 2020

A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years.

1 reference

12 December 2020

Can biochemical markers predict bone loss at the hip and spine?: a 4-year prospective study of 141 early postmenopausal women.

1 reference

12 December 2020

Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting

1 reference

12 December 2020

Rapid bone loss is associated with increased levels of biochemical markers

1 reference

12 December 2020

Biochemical markers as predictors of rates of bone loss after menopause

1 reference

12 December 2020

Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion

1 reference

12 December 2020

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

1 reference

12 December 2020

Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis

1 reference

12 December 2020

Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial

1 reference

12 December 2020

Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks

1 reference

12 December 2020

Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study

1 reference

12 December 2020

Oral weekly ibandronate prevents bone loss in postmenopausal women

1 reference

12 December 2020

Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women.

1 reference

12 December 2020

Serum osteocalcin in relation to calcaneal bone mineral density in elderly men and women: a 5-year follow-up

1 reference

12 December 2020

Commencing, continuing and stopping brisk walking: effects on bone mineral density, quantitative ultrasound of bone and markers of bone metabolism in postmenopausal women

1 reference

12 December 2020

Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers

1 reference

12 December 2020

Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1-year longitudinal study

1 reference

12 December 2020

Epilepsy and bone health in adults

1 reference

12 December 2020

Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women

1 reference

12 December 2020

Comparison of Weekly Treatment of Postmenopausal Osteoporosis with AlendronateVersusRisedronate Over Two Years

1 reference

12 December 2020

Effect of age-related chronic immobility on markers of bone turnover

1 reference

12 December 2020

Effect of immobilization upon renal synthesis of 1,25-dihydroxyvitamin D in disabled elderly stroke patients

1 reference

12 December 2020

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate: review of statistical analysis.

1 reference

12 December 2020

Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.

1 reference

12 December 2020

1 reference

12 December 2020

Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients

1 reference

12 December 2020

Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230)

1 reference

12 December 2020

Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment

1 reference

12 December 2020

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group

1 reference

12 December 2020

Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study

1 reference

12 December 2020

Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trial

1 reference

12 December 2020

Do Markers of Bone Resorption Add to Bone Mineral Density and Ultrasonographic Heel Measurement for the Prediction of Hip Fracture in Elderly Women? The EPIDOS Prospective Study

1 reference

12 December 2020

Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid

1 reference

12 December 2020

Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links

1 reference

12 December 2020

Risk factors for hip fracture in women with high BMD: EPIDOS study.

1 reference

12 December 2020

Biochemical markers of bone metabolism and prediction of fracture in elderly women.

1 reference

12 December 2020

Increased bone turnover in epileptic patients treated with carbamazepine

1 reference

12 December 2020

Determinants of bone loss from the femoral neck in women of different ages

1 reference

12 December 2020

Biochemical indices of bone turnover and the assessment of fracture probability

1 reference

12 December 2020

Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study.

1 reference

12 December 2020

The impact of compliance with osteoporosis therapy on fracture rates in actual practice.

1 reference

12 December 2020

Effects of low-dose prednisone on bone metabolism

1 reference

12 December 2020

An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone.

1 reference

12 December 2020

Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry

1 reference

12 December 2020

Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers

1 reference

12 December 2020

The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial

1 reference

12 December 2020

Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.

1 reference

12 December 2020

Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis

1 reference

12 December 2020

Acute fasting diminishes the circadian rhythm of biochemical markers of bone resorption.

1 reference

12 December 2020

Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.

1 reference

12 December 2020

Bone turnover markers and prediction of fracture: a prospective follow-up study of 1040 elderly women for a mean of 9 years

1 reference

12 December 2020

Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women

1 reference

12 December 2020

Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease

1 reference

12 December 2020

Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy

1 reference

12 December 2020

Regulation of osteoclast differentiation

1 reference

12 December 2020

Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

A longitudinal study of markers of bone turnover in Graves' disease and their value in predicting bone mineral density

1 reference

12 December 2020

Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae

1 reference

12 December 2020

Automatic-interactive measurement of resorption cavities in transiliac bone biopsies and correlation with deoxypyridinoline.

1 reference

12 December 2020

The contribution of trabecular architecture to cancellous bone quality

1 reference

12 December 2020

Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study

1 reference

12 December 2020

Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium

1 reference

12 December 2020

Identification of osteopenic women at high risk of fracture: the OFELY study.

1 reference

12 December 2020

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

1 reference

12 December 2020

Biochemical parameters associated with low bone density in healthy men and women

1 reference

12 December 2020

Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy

1 reference

12 December 2020

Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Markers of bone turnover for the prediction of fracture risk

1 reference

12 December 2020

Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial

1 reference

12 December 2020

Seasonal changes in calciotropic hormones, bone markers, and bone mineral density in elderly women

1 reference

12 December 2020

Long-term variability of markers of bone turnover in postmenopausal women and implications for their clinical use: the OFELY study.

1 reference

12 December 2020

The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study

1 reference

12 December 2020

Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women

1 reference

12 December 2020

One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis

1 reference

12 December 2020

Phenytoin increases markers of osteogenesis for the human species in vitro and in vivo

1 reference

12 December 2020

Decreased serum osteocalcin levels in phenprocoumon-treated patients

1 reference

12 December 2020

Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study

1 reference

12 December 2020

Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy

1 reference

12 December 2020

Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates

1 reference

12 December 2020

Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography

1 reference

12 December 2020

Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study

1 reference

12 December 2020

Pegvisomant-induced serum insulin-like growth factor-I normalization in patients with acromegaly returns elevated markers of bone turnover to normal

1 reference

12 December 2020

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

1 reference

12 December 2020

Analysis of the contribution of dydrogesterone to bone turnover changes in postmenopausal women commencing hormone replacement therapy.

1 reference

12 December 2020

Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover

1 reference

12 December 2020

Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronate

1 reference

12 December 2020

Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial

1 reference

12 December 2020

Intravenous zoledronic acid in postmenopausal women with low bone mineral density

1 reference

12 December 2020

Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis

1 reference

12 December 2020

The renal clearance of free and conjugated pyridinium cross-links of collagen

1 reference

12 December 2020

Fracture risk remains reduced one year after discontinuation of risedronate

1 reference

12 December 2020

Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis

1 reference

12 December 2020

Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism

1 reference

12 December 2020

Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: effects of growth and ageing

1 reference

12 December 2020

Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing's syndrome.

1 reference

12 December 2020

Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion

1 reference

12 December 2020

Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density

1 reference

12 December 2020

Treatment of postmenopausal osteoporosis

1 reference

12 December 2020

High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease.

1 reference

12 December 2020

Effect of active acromegaly and its treatment on parathyroid circadian rhythmicity and parathyroid target-organ sensitivity

1 reference

12 December 2020

Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group

1 reference

12 December 2020

Association of 12 serum biochemical markers of angiogenesis, tumour invasion and bone turnover with bone metastases from breast cancer: a crossectional and longitudinal evaluation

1 reference

12 December 2020

Mechanism of action of bisphosphonates

1 reference

12 December 2020

Role of gastrointestinal hormones in postprandial reduction of bone resorption

1 reference

12 December 2020

Preanalytical variability of biochemical markers of bone turnover.

1 reference

12 December 2020

Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis

1 reference

12 December 2020

Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal.

1 reference

12 December 2020

Molecular and cellular mechanisms of the anabolic effect of intermittent PTH

1 reference

12 December 2020

Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial

1 reference

12 December 2020

Effect of low-dose prednisone (with calcium and calcitriol supplementation) on calcium and bone metabolism in healthy volunteers

1 reference

12 December 2020

Effects of Atorvastatin on Bone in Postmenopausal Women with Dyslipidemia: A Double-Blind, Placebo-Controlled, Dose-Ranging Trial

1 reference

12 December 2020

Variability of collagen crosslinks: impact of sample collection period

1 reference

12 December 2020

The effects of progestins on bone density and bone metabolism in postmenopausal women: a randomized controlled trial

1 reference

12 December 2020

Reduced concentrations of collagen cross-links are associated with reduced strength of bone.

1 reference

12 December 2020

Use of matched historical controls to evaluate the anti-fracture efficacy of once-a-week risedronate

1 reference

12 December 2020

The degree of mineralization is a determinant of bone strength: a study on human calcanei.

1 reference

12 December 2020

Effects of alendronate and hormone replacement therapy, alone and in combination, on bone mass and markers of bone turnover in elderly women with osteoporosis

1 reference

12 December 2020

Plasma homocysteine and markers of bone metabolism in psychogeriatric patients

1 reference

12 December 2020

Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry

1 reference

12 December 2020

Statins and fracture risk. A systematic review

1 reference

12 December 2020

Predictors of fractures in elderly women.

1 reference

12 December 2020

Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients

1 reference

12 December 2020

The effect of atorvastatin on markers of bone turnover in patients with type 2 diabetes

1 reference

12 December 2020

Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study

1 reference

12 December 2020

Denosumab in postmenopausal women with low bone mineral density

1 reference

12 December 2020

Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial

1 reference

12 December 2020

Markers of bone turnover for monitoring treatment of osteoporosis with antiresorptive drugs

1 reference

12 December 2020

Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate

1 reference

12 December 2020

The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial

1 reference

12 December 2020

Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study

1 reference

12 December 2020

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

1 reference

12 December 2020

A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group

1 reference

12 December 2020

Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis

1 reference

12 December 2020

An orally active cathepsin K inhibitor, furan-2-carboxylic acid, 1-{1-[4-fluoro-2-(2-oxo-pyrrolidin-1-yl)-phenyl]-3-oxo-piperidin-4-ylcarbamoyl}-cyclohexyl)-amide (OST-4077), inhibits osteoclast activity in vitro and bone loss in ovariectomized rats

1 reference

12 December 2020

Effect of Monitoring Bone Turnover Markers on Persistence with Risedronate Treatment of Postmenopausal Osteoporosis

1 reference

12 December 2020

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

12 December 2020

Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy

1 reference

12 December 2020

Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients

1 reference

12 December 2020

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate

1 reference

12 December 2020

Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women

1 reference

12 December 2020

Calcaneal ultrasound but not bone turnover predicts fractures in vitamin D deficient frail elderly at high risk of falls.

1 reference

12 December 2020

The effect of short term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women

1 reference

12 December 2020

Hip and nonvertebral fracture prediction in nursing home patients: role of bone ultrasound and bone marker measurements

1 reference

12 December 2020

Rosiglitazone decreases serum bone-specific alkaline phosphatase activity in postmenopausal diabetic women

1 reference

12 December 2020

Evaluation of 41calcium as a new approach to assess changes in bone metabolism: effect of a bisphosphonate intervention in postmenopausal women with low bone mass

1 reference

12 December 2020

Ten years' experience with alendronate for osteoporosis in postmenopausal women

1 reference

12 December 2020

Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer

1 reference

12 December 2020

Effect of feeding on bone turnover markers and its impact on biological variability of measurements.

1 reference

12 December 2020

Short-term treatment with troglitazone decreases bone turnover in patients with type 2 diabetes mellitus.

1 reference

12 December 2020

Changes in biochemical markers and bone mass after withdrawal of ibandronate treatment: prediction of bone mass changes during treatment

1 reference

12 December 2020

Diurnal rhythm of CrossLaps in human serum

1 reference

12 December 2020

Effect of oral anticoagulant treatment on markers for calcium and bone metabolism.

1 reference

12 December 2020

Bone quality--the material and structural basis of bone strength and fragility

1 reference

12 December 2020

Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine

1 reference

12 December 2020

Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism

1 reference

12 December 2020

Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial

1 reference

12 December 2020

Loss of bone density with inhaled triamcinolone in Lung Health Study II.

1 reference

12 December 2020

Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study

1 reference

12 December 2020

Influence of physical mobility and season on 25-hydroxyvitamin D-parathyroid hormone interaction and bone remodelling in the elderly

1 reference

12 December 2020

Short-term risedronate treatment in postmenopausal women: effects on biochemical markers of bone turnover

1 reference

12 December 2020

A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy

1 reference

12 December 2020

Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group.

1 reference

12 December 2020

Effect of withdrawal of hormone replacement therapy on bone mass and bone turnover: the OFELY study.

1 reference

12 December 2020

The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica

1 reference

12 December 2020

Biochemical markers of bone turnover and bone loss at the lumbar spine and femoral neck: the Taiji study

1 reference

12 December 2020

Changes in biochemical markers after lower limb fractures

1 reference

12 December 2020

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

1 reference

12 December 2020

Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate

1 reference

12 December 2020

Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension

1 reference

12 December 2020

Impaired carboxylation of osteocalcin in warfarin-treated patients

1 reference

12 December 2020

Bone fragility: failure of periosteal apposition to compensate for increased endocortical resorption in postmenopausal women

1 reference

12 December 2020

Retracted: Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients

1 reference

12 December 2020

The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

10.1007/S00198-008-0660-9

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fug4i53twzgrth5la4bxygjokq

30 July 2022

mapped directly with Wikidata item

Dimensions Publication ID

1002143137

0 references

Fatcat ID

release_fug4i53twzgrth5la4bxygjokq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fug4i53twzgrth5la4bxygjokq

30 July 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/fug4i53twzgrth5la4bxygjokq

30 July 2022